ono 1078 has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kondo, M; Konno, K; Nagai, A; Nakata, J; Sakai, N; Takemura, H; Takizawa, T; Tamaoki, J | 1 |
| Kashii, T; Kawasaki, A; Kobayashi, M; Mizushima, Y; Oosaki, R | 1 |
| Hirasawa, Y; Hiwada, K; Kohno, N; Kondo, K; Sakai, K; Yokoyama, A | 1 |
| Fukutani, K; Hashimoto, K; Kawasaki, Y; Matsumoto, S; Nakamoto, N; Sasaki, T; Tokuyasu, H; Tomita, K; Yajima, H; Yamasaki, A | 1 |
| Abe, S; Fujishima, T; Hashimoto, M; Kon, H; Nakatsugawa, M; Saikai, T; Suzuki, A; Tanaka, H | 1 |
| Fukushima, C; Kawano, T; Kohno, S; Matsuse, H; Mitsuta, K; Obase, Y; Shimoda, T; Tomari, S | 1 |
| Baba, K; Niwa, S; Sakakibara, A; Takagi, K; Wakayama, H; Yagi, T | 1 |
| Asano, K; Fukunaga, K; Hakuno, H; Hasegawa, N; Kanazawa, M; Kudo, H; Matsuzaki, T; Nakamura, H; Shiomi, T; Suzuki, Y; Yamaguchi, K | 1 |
| Banno, K; Handa, M; Horiguchi, T; Kondo, R; Miyazaki, J; Sasaki, Y; Tachikawa, S | 1 |
| Hirose, M; Horiguchi, T; Kondo, R; Miyazaki, J; Shiga, M; Sugiyama, M; Tachikawa, S | 1 |
| Hirose, M; Horiguchi, T; Ito, T; Kondo, R; Shiga, M; Tachikawa, S | 1 |
8 trial(s) available for ono 1078 and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| Article | Year |
|---|---|
Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Beclomethasone; Chromones; Double-Blind Method; Female; Glucocorticoids; Humans; Leukotriene Antagonists; Male; Middle Aged; Procaterol; Substance Withdrawal Syndrome | 1997 |
Therapeutic effect of pranlukast, a selective cysteinyl leukotriene receptor antagonist, on bronchial asthma.
Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Asthma; Beclomethasone; Chromones; Female; Glucocorticoids; Humans; Hypersensitivity, Immediate; Leukotriene Antagonists; Male; Middle Aged; Peak Expiratory Flow Rate; Prednisolone | 1997 |
Effect of pranlukast, a leukotriene receptor antagonist, in patients with severe asthma refractory to corticosteroids.
Topics: Aged; Anti-Asthmatic Agents; Asthma; Beclomethasone; Chromones; Female; Glucocorticoids; Humans; Leukotriene Antagonists; Male; Middle Aged; Prednisolone | 1998 |
[Pranlukast allows reduction of inhaled steroid dose without deterioration in lung function in adult asthmatics].
Topics: Administration, Inhalation; Adult; Anti-Asthmatic Agents; Asthma; Beclomethasone; Case-Control Studies; Chromones; Drug Therapy, Combination; Female; Humans; Leukotriene Antagonists; Male; Middle Aged; Respiratory Function Tests | 1999 |
Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma.
Topics: Administration, Inhalation; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Chromones; Drug Therapy, Combination; Humans; Leukotriene Antagonists; Membrane Proteins; Peak Expiratory Flow Rate; Receptors, Leukotriene; Treatment Outcome | 2001 |
Long-term observations of the clinical course after step down of corticosteroid inhalation therapy in adult chronic asthmatics: correlation with serum levels of eosinophil cationic protein.
Topics: Adult; Aged; Analysis of Variance; Asthma; Beclomethasone; Benzoquinones; Blood Proteins; Chromones; Chronic Disease; Drug Therapy, Combination; Eosinophil Granule Proteins; Female; Glucocorticoids; Heptanoic Acids; Humans; Leukotriene Antagonists; Male; Middle Aged; Prognosis; Prospective Studies; Prostaglandin Antagonists; Respiratory Mechanics; Ribonucleases; Statistics, Nonparametric | 2002 |
Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast, in Japanese patients with moderate asthma.
Topics: Administration, Inhalation; Adult; Albuterol; Analysis of Variance; Androstadienes; Anti-Asthmatic Agents; Asian People; Asthma; Beclomethasone; Chromones; Female; Fluticasone; Forced Expiratory Volume; Genetic Carrier Screening; Glutathione Transferase; Humans; Japan; Leukotriene Antagonists; Male; Middle Aged; Polymorphism, Single Nucleotide; Promoter Regions, Genetic | 2002 |
[Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma].
Topics: Adult; Aged; Anti-Asthmatic Agents; Asthma; Beclomethasone; Biomarkers; Blood Proteins; Chromones; Drug Therapy, Combination; Eosinophil Granule Proteins; Eosinophils; Female; Humans; Leukocyte Count; Leukotriene Antagonists; Male; Middle Aged; Peak Expiratory Flow Rate; Ribonucleases; Treatment Outcome | 2003 |
3 other study(ies) available for ono 1078 and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| Article | Year |
|---|---|
Churg-Strauss syndrome after reduction of inhaled corticosteroid in a patient treated with pranlukast for asthma.
Topics: Administration, Inhalation; Administration, Topical; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Chromones; Churg-Strauss Syndrome; Female; Glucocorticoids; Humans; Leukotriene Antagonists; Middle Aged | 2001 |
Evaluation of the combined effect of pranlukast during high-dose steroid inhalation.
Topics: Administration, Inhalation; Adrenergic beta-Antagonists; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Blood Proteins; Chromones; Eosinophil Granule Proteins; Eosinophils; Female; Humans; Leukocyte Count; Male; Middle Aged; Respiratory Function Tests; Ribonucleases; Treatment Outcome | 2002 |
Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Aged; Anti-Asthmatic Agents; Asthma; Beclomethasone; Chromones; Eosinophils; Female; Forced Expiratory Volume; Humans; Leukocyte Count; Leukotriene Antagonists; Male; Middle Aged; Peak Expiratory Flow Rate | 2003 |